Brian J. Ward

12.5k total citations · 1 hit paper
236 papers, 8.9k citations indexed

About

Brian J. Ward is a scholar working on Epidemiology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Brian J. Ward has authored 236 papers receiving a total of 8.9k indexed citations (citations by other indexed papers that have themselves been cited), including 128 papers in Epidemiology, 73 papers in Infectious Diseases and 48 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Brian J. Ward's work include Influenza Virus Research Studies (52 papers), Respiratory viral infections research (36 papers) and Virology and Viral Diseases (34 papers). Brian J. Ward is often cited by papers focused on Influenza Virus Research Studies (52 papers), Respiratory viral infections research (36 papers) and Virology and Viral Diseases (34 papers). Brian J. Ward collaborates with scholars based in Canada, United States and Zimbabwe. Brian J. Ward's co-authors include Diane E. Griffin, Nathalie Landry, Lawrence H. Moulton, Sonia Trépanier, Peter Iliff, Kusum Nathoo, Jean H. Humphrey, Lynn S. Zijenah, Stéphane Pillet and Edmore Marinda and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Nature Medicine.

In The Last Decade

Brian J. Ward

234 papers receiving 8.5k citations

Hit Papers

Phase 1 randomized trial of a plant-derived virus-like pa... 2021 2026 2022 2024 2021 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian J. Ward Canada 53 4.2k 3.1k 2.1k 1.3k 1.2k 236 8.9k
Jerald Sadoff United States 59 4.2k 1.0× 3.3k 1.1× 4.5k 2.1× 2.9k 2.3× 1.7k 1.4× 188 12.7k
Tobias R. Kollmann Canada 49 2.1k 0.5× 2.0k 0.6× 3.0k 1.5× 1.9k 1.4× 635 0.5× 165 8.0k
Jeffrey P. Davis United States 41 2.5k 0.6× 3.8k 1.2× 608 0.3× 1.3k 1.0× 1.1k 0.9× 142 8.6k
Edward T. Ryan United States 52 1.2k 0.3× 2.9k 0.9× 1.1k 0.6× 1.1k 0.9× 1.6k 1.3× 259 8.7k
Antonio Cassone Italy 66 6.0k 1.4× 9.1k 3.0× 2.3k 1.1× 3.1k 2.3× 2.1k 1.7× 311 14.9k
John B. Robbins United States 69 6.0k 1.5× 4.2k 1.4× 2.5k 1.2× 3.8k 2.9× 1.1k 0.9× 275 16.1k
Geert Leroux‐Roels Belgium 58 6.9k 1.7× 2.2k 0.7× 3.0k 1.5× 1.8k 1.4× 745 0.6× 297 11.5k
Stanley A. Plotkin United States 70 10.6k 2.5× 7.4k 2.4× 3.6k 1.7× 3.6k 2.7× 1.3k 1.1× 461 20.2k
Gregory A. Poland United States 65 7.7k 1.8× 4.7k 1.5× 3.9k 1.8× 3.7k 2.9× 1.0k 0.9× 411 16.2k
Michael W. Russell United States 62 2.3k 0.6× 1.7k 0.6× 4.1k 2.0× 2.1k 1.6× 1.7k 1.4× 198 11.2k

Countries citing papers authored by Brian J. Ward

Since Specialization
Citations

This map shows the geographic impact of Brian J. Ward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian J. Ward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian J. Ward more than expected).

Fields of papers citing papers by Brian J. Ward

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian J. Ward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian J. Ward. The network helps show where Brian J. Ward may publish in the future.

Co-authorship network of co-authors of Brian J. Ward

This figure shows the co-authorship network connecting the top 25 collaborators of Brian J. Ward. A scholar is included among the top collaborators of Brian J. Ward based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian J. Ward. Brian J. Ward is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Shapiro, Janna R., Guadalupe Andreani, Mélanie Bérubé, et al.. (2023). Development and characterization of a plant-derived norovirus-like particle vaccine. Vaccine. 41(41). 6008–6016. 4 indexed citations
4.
Lavoie, Pierre‐Olivier, et al.. (2022). Elimination of receptor binding by influenza hemagglutinin improves vaccine-induced immunity. npj Vaccines. 7(1). 42–42. 11 indexed citations
5.
Poeta, Maurizio Del, Brian J. Ward, Benjamin Greenberg, et al.. (2022). Cryptococcal Meningitis Reported With Fingolimod Treatment. Neurology Neuroimmunology & Neuroinflammation. 9(3). 17 indexed citations
6.
McClymont, Elisabeth, Jason Brophy, Vinita Dubey, et al.. (2021). Is ‘conflict of interest’ a Misnomer? Managing interests in immunization research and evaluation. Human Vaccines & Immunotherapeutics. 18(1). 1879580–1879580. 1 indexed citations
7.
Machado, Marina Amaral de Ávila, Cristiano Soares de Moura, Michał Abrahamowicz, et al.. (2021). Relative effectiveness of influenza vaccines in elderly persons in the United States, 2012/2013-2017/2018 seasons. npj Vaccines. 6(1). 108–108. 10 indexed citations
8.
Ward, Brian J., Philipe Gobeil, Annie Séguin, et al.. (2021). Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19. Nature Medicine. 27(6). 1071–1078. 214 indexed citations breakdown →
9.
Hemmer, Bernhard, Bruce Cree, Benjamin Greenberg, et al.. (2021). COVID-19 Infection in Fingolimod- or Siponimod-Treated Patients. Neurology Neuroimmunology & Neuroinflammation. 9(1). 25 indexed citations
10.
Gomord, Véronique, Anne‐Catherine Fitchette, Elizabeth D. Fixman, et al.. (2020). Design, production and immunomodulatory potency of a novel allergen bioparticle. PLoS ONE. 15(12). e0242867–e0242867. 12 indexed citations
11.
Макарков, А. И., Makan Golizeh, Sabrina Chierzi, et al.. (2019). Plant-derived virus-like particle vaccines drive cross-presentation of influenza A hemagglutinin peptides by human monocyte-derived macrophages. npj Vaccines. 4(1). 17–17. 24 indexed citations
13.
Ang, Jann C., Biao Wang, Florian Krammer, et al.. (2019). Comparative Immunogenicity of the 2014–2015 Northern Hemisphere Trivalent IIV and LAIV against Influenza A Viruses in Children. Vaccines. 7(3). 87–87. 8 indexed citations
14.
Pillet, Stéphane, et al.. (2019). A plant-derived VLP influenza vaccine elicits a balanced immune response even in very old mice with co-morbidities. PLoS ONE. 14(1). e0210009–e0210009. 15 indexed citations
15.
Guak, Hannah, et al.. (2018). Characterization of the innate stimulatory capacity of plant-derived virus-like particles bearing influenza hemagglutinin. Vaccine. 36(52). 8028–8038. 13 indexed citations
16.
Wang, Biao, Margaret L. Russell, Jennifer Newton, et al.. (2017). Single radial haemolysis compared to haemagglutinin inhibition and microneutralization as a correlate of protection against influenza A H3N2 in children and adolescents. Influenza and Other Respiratory Viruses. 11(3). 283–288. 16 indexed citations
17.
Mutasa, Kuda, Robert Ntozini, Andrew J. Prendergast, et al.. (2012). Impact of Six-week Viral Load on Mortality in HIV-infected Zimbabwean Infants. The Pediatric Infectious Disease Journal. 31(9). 948–950. 6 indexed citations
18.
Pasetti, Marcela F., Aldo Arturo Reséndiz‐Albor, Karina Ramírez, et al.. (2007). Heterologous Prime–Boost Strategy to Immunize Very Young Infants against Measles: Pre-clinical Studies in Rhesus Macaques. Clinical Pharmacology & Therapeutics. 82(6). 672–685. 27 indexed citations
19.
Ward, Brian J., et al.. (1997). Association between measles infection and the occurrence of chronic inflammatory bowel disease.. PubMed. 23(1). 1–5; discussion 5. 5 indexed citations
20.
Bamber, Sheila, et al.. (1980). Transplantation of the gonads of hypogonadal ( hpg ) mice. Reproduction. 58(1). 249–252. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026